thiobenzyl benzyloxycarbonyl-l-lysinate has been researched along with Leukemia in 1 studies
*Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, RA; Pores-Fernando, AT; Wurth, GA; Zweifach, A | 1 |
1 other study(ies) available for thiobenzyl benzyloxycarbonyl-l-lysinate and Leukemia
| Article | Year |
|---|---|
Exocytic responses of single leukaemic human cytotoxic T lymphocytes stimulated by agents that bypass the T cell receptor.
Topics: Cell Degranulation; Cell Line, Tumor; Flow Cytometry; Granzymes; Humans; Leukemia; Lysine; Lysosomal-Associated Membrane Protein 1; Membrane Glycoproteins; Perforin; Pore Forming Cytotoxic Proteins; Receptors, Antigen, T-Cell; Serine Endopeptidases; Stimulation, Chemical; T-Lymphocytes, Cytotoxic; Tetradecanoylphorbol Acetate; Thapsigargin | 2005 |